180 related articles for article (PubMed ID: 8340137)
1. [Therapeutic strategies against mediators of septic shock].
Zabel P; Schade FU
Immun Infekt; 1993 Apr; 21(2):45-50. PubMed ID: 8340137
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature.
Dofferhoff AS; Vellenga E; Limburg PC; van Zanten A; Mulder PO; Weits J
Neth J Med; 1991 Aug; 39(1-2):45-62. PubMed ID: 1961351
[TBL] [Abstract][Full Text] [Related]
3. Biology of proinflammatory cytokines and their antagonists.
Moldawer LL
Crit Care Med; 1994 Jul; 22(7):S3-7. PubMed ID: 8026189
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endogenous TNF formation by pentoxifylline.
Zabel P; Schade FU; Schlaak M
Immunobiology; 1993 Apr; 187(3-5):447-63. PubMed ID: 8330908
[TBL] [Abstract][Full Text] [Related]
5. [Pentoxifylline--an inhibitor of the synthesis of tumor necrosis factor alpha].
Zabel P; Schade FU; Schlaak M
Immun Infekt; 1992 Jul; 20(3):80-3. PubMed ID: 1500076
[TBL] [Abstract][Full Text] [Related]
6. Role of TNF-alpha, IL-1beta and IL-6 in the local tissue damage induced by Bothrops asper snake venom: an experimental assessment in mice.
Chaves F; Teixeira CF; Gutiérrez JM
Toxicon; 2005 Feb; 45(2):171-8. PubMed ID: 15626366
[TBL] [Abstract][Full Text] [Related]
7. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493.
D'Souza MJ; Oettinger CW; Milton GV; Tracey KJ
J Interferon Cytokine Res; 1999 Oct; 19(10):1125-33. PubMed ID: 10547152
[TBL] [Abstract][Full Text] [Related]
8. [Endotoxins of gram-negative bacteria, cytokines and the concept of septic shock: present state of the problem].
Beloborodov VB; Dzheksenbaev OSh
Anesteziol Reanimatol; 1991; (4):41-3. PubMed ID: 1952239
[No Abstract] [Full Text] [Related]
9. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production.
Greeneltch KM; Haudenschild CC; Keegan AD; Shi Y
Brain Behav Immun; 2004 Sep; 18(5):476-84. PubMed ID: 15265541
[TBL] [Abstract][Full Text] [Related]
10. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson RC
Nature; 1990 Dec; 348(6301):550-2. PubMed ID: 2147233
[TBL] [Abstract][Full Text] [Related]
12. [Cytokines and antagonists in septic shock].
Girardin E; Dayer JM
Schweiz Med Wochenschr; 1993 Mar; 123(11):480-91. PubMed ID: 8386392
[TBL] [Abstract][Full Text] [Related]
13. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
Beutler B
New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor.
Schade UF
Circ Shock; 1990 Jun; 31(2):171-81. PubMed ID: 2344657
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG
J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357
[TBL] [Abstract][Full Text] [Related]
17. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
[TBL] [Abstract][Full Text] [Related]
18. Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo.
Bertini R; Mengozzi M; Bianchi M; Sipe JD; Ghezzi P
Int J Immunopharmacol; 1991; 13(8):1085-90. PubMed ID: 1814847
[TBL] [Abstract][Full Text] [Related]
19. Study of pentoxifylline induced modulation of TNF alpha and interleukin-6 secretion in healthy and septic patients by the use of an ex-vivo model on whole blood.
Bienvenu J; Coulon L; Barbier Y; Barbier M; Doche C; Lepape A; Guenounou M
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S65-7. PubMed ID: 1340532
[TBL] [Abstract][Full Text] [Related]
20. [Cytokines and severe sepsis].
Baumgartner JD; Heumann D
Rev Prat; 1993 Mar; 43(5):559-63. PubMed ID: 8341926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
